chartexchange

BNTC
Benitec Biopharma Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
8.24USD+1.104%(+0.09)128,832
After-hoursNov 18, 2026 4:34:30 PM EST
8.11USD-1.578%(-0.13)
Loading…
Loading…
298.34M
Healthcare
Biotechnology
HQ
Hayward, CA, USA
Previous Close
$8.15
Beta
1.62
52-Week High
$14.39 2025-12-31
52-Week Low
$7.89 2026-10-28
SMA 50
$9.41
SMA 200
$11.32
Avg. Vol 10D
190,490
Avg. Vol 30D
183,257
Avg. Vol 90D
165,984
Relative Vol
0.70
34.01M
0.4300%
1,500,000
10,166
Jun 1, 2018 · $0.003
Jul 26, 2023 · 1-for-17 (reverse)
BNTC Profile

benitec biopharma is using patented 'gene-silencing' technology to develop drugs for chronic and life-threatening human diseases. our transformational technology, ddrnai, targets and 'turns off' specific genes related to disease, providing lasting treatment and potentially cure with a single dose. compared to traditional approaches to rna intereference, ddrnai is easier to deliver, safer to us, more targeted and more efficient. benitec has a pipeline of in-house and partnered drug development programs based on ddrnai, including hepatitis c and b and cancer-associated pain. ddrnai has the potential to silence genes related to thousands of human diseases and is protected by over 40 global patents. the technology is available from benitec under a variety of licence options.

BNTC Performance
PeriodPriceDateChangeBeta
1W9.092026-11-12-9.13%4.000
1M8.362026-10-19-1.20%1.985
3M13.382026-08-19-38.27%1.755
6M10.722026-05-19-22.95%1.434
1Y13.102025-11-19-36.95%1.617
2Y9.882024-11-19-16.40%—
5Y54.402021-11-19-84.82%0.535
BNTC Stock Summary

Benitec Biopharma Inc. Common Stock (NASDAQ:BNTC) stock price today is $8.26, and today's volume is 128,832. BNTC is up 1.350% today. The 30 day average volume is 183,257. BNTC market cap is $298.34M with 36.12M shares outstanding.